We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · December 29, 2019

Adoption of New Glucose-Lowering Medications in the US

Diabetes Technology & Therapeutics


Additional Info

Diabetes Technology & Therapeutics
Adoption of New Glucose-Lowering Medications in the U.S. – The Case of SGLT2 Inhibitors: Nationwide Cohort Study
Diabetes Technol. Ther. 2019 Dec 01;21(12)702-712, RG McCoy, HJ Dykhoff, L Sangaralingham, JS Ross, P Karaca-Mandic, VM Montori, ND Shah

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading